Sort   by:  
 Page size 
UnknownSustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE.
Not available
S-EPMC8796656 | biostudies-literature
UnknownPrognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIA.
Not available
S-EPMC8832474 | biostudies-literature
UnknownTreatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis.
Not available
S-EPMC9056460 | biostudies-literature
UnknownImmune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19.
Not available
S-EPMC11237013 | biostudies-literature
UnknownPotential biomarkers of major depression diagnosis and chronicity.
Not available
S-EPMC8480905 | biostudies-literature
UnknownPathophysiology of Major Depression by Clinical Stages.
Not available
S-EPMC8374436 | biostudies-literature
UnknownImmune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies.
Not available
S-EPMC8669666 | biostudies-literature
UnknownPreclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
Not available
S-EPMC10033443 | biostudies-literature
UnknownEffect of Asymptomatic and Symptomatic COVID-19 on Acute Ischemic Stroke Revascularization Outcomes.
Not available
S-EPMC10734790 | biostudies-literature
UnknownEpidemiological characterization of rare diseases in Brazil: A retrospective study of the Brazilian Rare Diseases Network.
Not available
S-EPMC11523578 | biostudies-literature
Sort   by:  
 Page size